The European Haemophilia Consortium (EHC) works closely with key European and international partners, including other patients’ groups and medical associations.

Since its inception, the EHC has maintained formal links with the World Federation of Hemophilia (WFH). The WFH is an international organisation representing people with rare bleeding disorders from 147 countries, including Europe. The WFH recognises the EHC as a separate organisation and observer to its General Assembly. The two organisations signed a Memorandum of Understanding (MoU) in 2004 to enhance their collaboration in European countries. This MoU was revised in 2016 and then in 2021

The EHC works closely with the European Association for Haemophilia and Allied Disorders (EAHAD). EAHAD is a multi-disciplinary association of health care professionals who provide care for individuals with haemophilia and other bleeding disorders. Both organisations signed an MoU in 2013. This MoU was revised in 2024.

The EHC is a member organisation of the European Organisation for Rare Diseases (EURORDIS), the Platform of Plasma Protein Users (PLUS) and the European Patients Forum (EPF).